Science Advances · 11 September 2026 · From issue 36
Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1
In mice, blocking a protein called SPP1 made immune therapy shrink KRAS-mutant lung tumors better.
Xin Zhang, Qian Hao et al.
Integrity screen: passed (3 checks) Checked 16 September 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue